S&P assigns Boston Scientific notes A

Standard & Poor's said it assigned its A rating to Boston Scientific Corp.'s $600 million 10- and 30-year senior unsecured notes.

Existing ratings on the company, including the A long-term corporate credit rating and A-1 short-term rating, were affirmed. The outlook is stable.

S&P said the ratings reflect Boston Scientific's broad portfolio of market-leading, minimally invasive medical devices and its deep and diverse new product pipeline, which mitigate the risks of participating in extremely competitive technology markets.

The agency added it believes that the company's conservative financial profile, highlighted by strong credit protection metrics and significant cash reserves, allows it to make the substantial investments required to maintain its leadership position in this industry.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.